These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31101018)

  • 1. The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial.
    Raimann JG; Abbas SR; Liu L; Larive B; Beck G; Kotanko P; Levin NW; Handelman G;
    BMC Nephrol; 2019 May; 20(1):179. PubMed ID: 31101018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Beck G; Lindsay RM; Rocco MV; Chertow GM; Levin NW;
    Kidney Blood Press Res; 2021; 46(6):768-776. PubMed ID: 34644706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.
    Ornt DB; Larive B; Rastogi A; Rashid M; Daugirdas JT; Hernandez A; Kurella Tamura M; Suri RS; Levin NW; Kliger AS;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1888-98. PubMed ID: 23358899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.
    Huang SS; Kaysen GA; Levin NW; Kliger AS; Beck GJ; Rocco MV; Filler G; Lindsay RM;
    Hemodial Int; 2019 Jul; 23(3):297-305. PubMed ID: 30861262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Schiller BM; Yang PC; Rajagopalan S;
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):251-61. PubMed ID: 22360996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.
    Kotanko P; Garg AX; Depner T; Pierratos A; Chan CT; Levin NW; Greene T; Larive B; Beck GJ; Gassman J; Kliger AS; Stokes JB;
    Hemodial Int; 2015 Jul; 19(3):386-401. PubMed ID: 25560227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial.
    Chan CT; Chertow GM; Daugirdas JT; Greene TH; Kotanko P; Larive B; Pierratos A; Stokes JB;
    Nephrol Dial Transplant; 2014 Jan; 29(1):168-78. PubMed ID: 24078335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.
    Rocco MV; Larive B; Eggers PW; Beck GJ; Chertow GM; Levin NW; Kliger AS;
    Am J Kidney Dis; 2011 Jan; 57(1):90-100. PubMed ID: 21122961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo JC; Rocco MV; Kliger AS;
    Hemodial Int; 2020 Apr; 24(2):162-174. PubMed ID: 31826326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis.
    Sirover WD; Liu Y; Logan A; Hunter K; Benz RL; Prasad D; Avila J; Venkatchalam T; Weisberg LS; Handelman GJ
    J Ren Nutr; 2015 May; 25(3):292-300. PubMed ID: 25455040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Wave Alternans, Heart Rate Turbulence, and Ventricular Ectopy in Standard versus Daily Hemodialysis: Results from the FHN Daily Trial.
    Kaplan RM; Herzog CA; Larive B; Subacius H; Nearing BD; Verrier R; Passman RS
    Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):566-571. PubMed ID: 27778458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.
    Unruh ML; Larive B; Chertow GM; Eggers PW; Garg AX; Gassman J; Tarallo M; Finkelstein FO; Kimmel PL;
    Am J Kidney Dis; 2013 May; 61(5):748-58. PubMed ID: 23332990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.
    Rocco MV; Daugirdas JT; Greene T; Lockridge RS; Chan C; Pierratos A; Lindsay R; Larive B; Chertow GM; Beck GJ; Eggers PW; Kliger AS;
    Am J Kidney Dis; 2015 Sep; 66(3):459-68. PubMed ID: 25863828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solute clearances and fluid removal in the frequent hemodialysis network trials.
    Greene T; Daugirdas JT; Depner TA; Gotch F; Kuhlman M; ; ;
    Am J Kidney Dis; 2009 May; 53(5):835-44. PubMed ID: 19339093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
    Moloney BM; Chertow GM; Mc Causland FR
    Am J Nephrol; 2024; 55(4):409-416. PubMed ID: 38781949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.
    Hall YN; Larive B; Painter P; Kaysen GA; Lindsay RM; Nissenson AR; Unruh ML; Rocco MV; Chertow GM;
    Clin J Am Soc Nephrol; 2012 May; 7(5):782-94. PubMed ID: 22422538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
    Montazerifar F; Hashemi M; Karajibani M; Dikshit M
    J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.